Market closed

PROCEPT BioRobotics/$PRCT

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About PROCEPT BioRobotics

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

Ticker

$PRCT
Trading on

Industry

Health Care Equipment & Supplies

Employees

626

PRCT Metrics

BasicAdvanced
$5.3B
Market cap
-
P/E ratio
-$1.95
EPS
1.03
Beta
-
Dividend rate
$5.3B
1.03
$95.55
$30.84
1.1M
6.021
4.955
32.667
34.259
-24.53%
-16.73%
-37.02%
25.012
21.06
21.14
-48.264
71.71%
-16.22%
93.56%
-38.76%

What the Analysts think about PRCT

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for PROCEPT BioRobotics stock.

PRCT Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PRCT Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PRCT

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for PROCEPT BioRobotics stock?

PROCEPT BioRobotics (PRCT) has a market cap of $5.3B as of November 13, 2024.

What is the P/E ratio for PROCEPT BioRobotics stock?

The price to earnings (P/E) ratio for PROCEPT BioRobotics (PRCT) stock is 0 as of November 13, 2024.

Does PROCEPT BioRobotics stock pay dividends?

No, PROCEPT BioRobotics (PRCT) stock does not pay dividends to its shareholders as of November 13, 2024.

When is the next PROCEPT BioRobotics dividend payment date?

PROCEPT BioRobotics (PRCT) stock does not pay dividends to its shareholders.

What is the beta indicator for PROCEPT BioRobotics?

PROCEPT BioRobotics (PRCT) has a beta rating of 1.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.